Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide added to insulin glargine + metformin in type 2 diabetes
2008-007335-40Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Lixisenatide arm with Placebo arm (2 arms). Primary endpoint: Change in HbA1c from baseline to week 24. Started Aug 2009; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-007335-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007335-40.